{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fquadshot-news-podcast.simplecast.com%2Fepisodes%2F10222019-get-to-the-point-kciY1aEG","width":444,"version":"1.0","type":"rich","title":"10.22.2019 - Get To The Point","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/d4956b26-f7a3-4f47-a83d-9293649d65c8/ec08e780-4e06-4c01-8109-4e894d682296/qs_sqaure.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/c674cc90-27c3-4a34-bce4-e1fe6083de3b\" height=\"200\" width=\"100%\" title=\"10.22.2019 - Get To The Point\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Spine SBRT constraints, HYPRO, CDDP > Cetuximab, and Psoriasis\n\n\nquadshotnews@gmail.com\n@QuadShotNews"}